Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)

Market Cap	1.82B +11.4%
Revenue (ttm)	1.38B +18.1%
Net Income	164.28M +48.5%
EPS	2.72 +48.0%
Shares Out	59.83M
PE Ratio	11.18
Forward PE	n/a
Dividend	0.95 (3.13%)
Ex-Dividend Date	Aug 26, 2025

Volume	259,201
Average Volume	133,509
Open	30.15
Previous Close	30.20
Day's Range	29.90 - 30.50
52-Week Range	28.24 - 32.90
Beta	0.20
RSI	75.34
Earnings Date	Mar 13, 2026

About TPEX:4111

Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerve agents; antihistamines and antipruritics; antipyretics and analgesics; antitussives and...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1962
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4111

Financial Performance

In 2025, TPEX:4111's revenue was 1.38 billion, an increase of 18.11% compared to the previous year's 1.17 billion. Earnings were 164.28 million, an increase of 48.49%.